Moving from inspiration into practice

Cura Research Funding

As part of its mission, Cura seeks to raise funds to support research to catalyze better health and address areas of unmet medical need including the development of a wide array of cell therapies, gene therapies and immunotherapies. Through its collaborative, interdisciplinary network, Cura supports research that addresses the underlying causes of disease as opposed to conventional approaches, which focus on treating symptoms.

Research We Support

FDA Approves Study to Investigate the Use of Cell Therapy to Treat COVID-19 Related Multisystem Inflammatory Syndrome in Children (MIS-C)

The Cura Foundation in collaboration with The Marcus Foundation, Sanford Health and Alliance for Cell Therapy Now, is supporting a clinical trial of human cord tissue mesenchymal stromal cells (hCT-MSC) to treat children with Multisystem Inflammatory Syndrome in Children (MIS-C). The trial is being led by Dr. Joanne Kurtzberg at Duke University to determine if infusions of hCT-MSCs are safe and can suppress the hyper-inflammatory response and positively impact the symptom course and duration, as well as the long-term effects of this life-threatening syndrome. The hCT-MSCs are manufactured in the Robertson GMP Cell Manufacturing Laboratory at Duke. The U.S. Food and Drug Administration (FDA) approved the Investigational New Drug (IND) Application, and Dr. Kurtzberg will proceed with a multi-site pilot study later this month. Learn more

Our Partnerships

Alliance for Cell Therapy Now

Alliance for Cell Therapy Now (ACT Now) is an independent, non-profit organization devoted to advancing the availability of and access to safe and effective cell therapies for patients in need. ACT Now convenes experts and stakeholders to develop and advance sound policies that will improve the development, manufacturing, delivery, and improvement of regenerative cell therapies. Learn more

Sanford Health

Sanford Health, one of the largest health systems in the United States, is dedicated to the integrated delivery of health care, genomic medicine, senior care and services, global clinics, research and affordable insurance. Headquartered in Sioux Falls, South Dakota, the organization includes 46 hospitals, 1,400 physicians and more than 200 Good Samaritan Society senior care locations in 26 states and 10 countries. Learn more about Sanford Health’s transformative work to improve the human condition at sanfordhealth.org or Sanford Health News.

WNICER

WNICER is a multinational network with the goal to impact chronic conditions through clinical research in order to produce evidence-based trials and interventions that increase our knowledge of health and disease, improving the quality of our health care, and the development of devices and therapies that can directly benefit the patient. WNICER is committed to implementing programs that aim to shorten the time from discovery to patient application with translational research, innovative clinical trials and implementation strategies that impact clinical care that are all supported by a strong continuing medical education program. Learn more

Close Menu